Authors

• Manish Jain (ORCID: https://orcid.org/0000-0001-6545-8838)
• Yoshiya Tanaka (ORCID: https://orcid.org/0000-0002-0807-7139)
• Paul Emery (ORCID: https://orcid.org/0000-0002-7429-8482)
• Koji Kato (ORCID: https://orcid.org/0000-0002-5815-4585)
• Kyle Carter
• Sebastian Meerwein
• Juan Ignacio Vargas (ORCID: https://orcid.org/0000-0001-8533-8825)
• Stanley Cohen (ORCID: https://orcid.org/0000-0002-9226-979X)
• William F. C. Rigby (ORCID: https://orcid.org/0000-0002-1382-7299)
• Josef S Smolen (ORCID: https://orcid.org/0000-0002-4302-8877)
• Charles D. Phillips (ORCID: https://orcid.org/0000-0001-8706-408X)
• Nasser Khan

Institutions

• Dartmouth Institute for Health Policy and Clinical Practice (US)
• University of Occupational and Environmental Health Japan (JP)
• AbbVie (United States) (US)
• NIHR Leeds Musculoskeletal Biomedical Research Unit (GB)
• Dartmouth Psychiatric Research Center (US)
• AbbVie (Germany) (DE)
• Nagoya Kyouritsu Hospital (JP)
• Medical University of Vienna (AT)
• The University of Texas Southwestern Medical Center (US)

Publication Details

Journal

RMD Open

Published

2025-04-01

DOI

https://doi.org/10.1136/rmdopen-2024-005051

Citations

3

Primary Topic

Rheumatoid Arthritis Research and Therapies

Type

article

Field-Weighted Citation Impact

5.00

Funders

• AbbVie